Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ovulation induction in clomiphene-resistant polycystic ovary syndrome
PACTR201611001569368Completed
- Sponsor
- Menoufia University
- Start
- May 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of ethinyl estradiol + drospirenone and letrozole in polycystic ovary syndrome (PCOS), sponsored by Menoufia University. Primary endpoint: Ovulation. Started May 2016; status: completed.
02
Drugs
ethinyl estradiol + drospirenoneletrozole
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on PACTR201611001569368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201611001569368.